Intervertebral disc regeneration using platelet-rich plasma and biodegradable gelatin hydrogel microspheres.

This study evaluated the regenerative effects of platelet-rich plasma (PRP) for the degenerated intervertebral disc (IVD) in vivo. After induction of IVD degeneration in rabbits, we prepared PRP by centrifuging blood obtained from these rabbits. These PRP were injected into the nucleus pulposus (NP) of the degenerated IVDs after impregnation into gelatin hydrogel microspheres that can immobilize PRP growth factors physiochemically and release them in a sustained manner with the degradation of the microspheres. As controls, microspheres impregnated with phosphate-buffered saline (PBS) and PRP without microspheres were similarly injected. Histologically, notable progress in IVD degeneration with time courses was observed in the PBS control, PRP-only, and sham groups. In contrast, progress was remarkably suppressed over the 8-week period in the PRP group. Moreover, in immunohistochemistry, intense immunostaining for proteoglycan in the NP and inner layer of the annulus fibrosus was observed 8 weeks after administration of PRP-impregnated microspheres. Almost all microspheres were indistinct 8 weeks after the injection, and there were no apparent side effects in this study. Our results suggest that the combined administration of PRP and gelatin hydrogel microspheres into the IVD may be a promising therapeutic modality for IVD degeneration.

[1]  E. Thonar,et al.  Platelet-Rich Plasma (PRP) Stimulates the Extracellular Matrix Metabolism of Porcine Nucleus Pulposus and Anulus Fibrosus Cells Cultured in Alginate Beads , 2006, Spine.

[2]  E. Thonar,et al.  Osteogenic Protein-1 Injection Into a Degenerated Disc Induces the Restoration of Disc Height and Structural Changes in the Rabbit Anular Puncture Model , 2006, Spine.

[3]  Y. Tabata,et al.  Augmented bone regeneration activity of platelet-rich plasma by biodegradable gelatin hydrogel. , 2005, Tissue engineering.

[4]  T. Smit,et al.  Bioabsorbable interbody cages in a sheep cervical spine fusion model. , 2005, Spine.

[5]  S. Chubinskaya,et al.  Osteogenic Protein-1 (Osteogenic Protein-1/Bone Morphogenetic Protein-7) Inhibits Degeneration and Pain-Related Behavior Induced by Chronically Compressed Nucleus Pulposus in the Rat , 2005, Spine.

[6]  P. Mummaneni,et al.  Current Treatment Strategies for the Painful Lumbar Motion Segment: Posterolateral Fusion Versus Interbody Fusion , 2005, Spine.

[7]  E. Thonar,et al.  Osteogenic protein-1 is most effective in stimulating nucleus pulposus and annulus fibrosus cells to repair their matrix after chondroitinase ABC-induced in vitro chemonucleolysis. , 2005, The spine journal : official journal of the North American Spine Society.

[8]  W. Hutton,et al.  Disc Degeneration in the Rabbit: A Biochemical and Radiological Comparison Between Four Disc Injury Models , 2005, Spine.

[9]  O. Johnell,et al.  The economic cost of low back pain in sweden in 2001 , 2005, Acta orthopaedica.

[10]  Lars G Gilbertson,et al.  A Slowly Progressive and Reproducible Animal Model of Intervertebral Disc Degeneration Characterized by MRI, X-Ray, and Histology , 2005, Spine.

[11]  E. Thonar,et al.  Intradiscal Administration of Osteogenic Protein-1 Increases Intervertebral Disc Height and Proteoglycan Content in the Nucleus Pulposus in Normal Adolescent Rabbits , 2005, Spine.

[12]  H. An,et al.  Growth Factors and Treatment of Intervertebral Disc Degeneration , 2004, Spine.

[13]  B. Eppley,et al.  Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. , 2004, Plastic and reconstructive surgery.

[14]  Yasuhiko Tabata,et al.  Collagenous matrices as release carriers of exogenous growth factors. , 2004, Biomaterials.

[15]  S. Nishimoto,et al.  Efficacy of platelet-rich plasma in alveolar bone grafting. , 2004, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[16]  R. Marx.  Platelet-rich plasma: evidence to support its use. , 2004, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[17]  G. Andersson,et al.  Low Back Pain: Pathophysiology and Management , 2004, The Journal of the American Academy of Orthopaedic Surgeons.

[18]  Ziv Mazor,et al.  Platelet-Rich Plasma for Bone Graft Enhancement in Sinus Floor Augmentation With Simultaneous Implant Placement: Patient Series Study , 2004, Implant dentistry.

[19]  J. Lotz,et al.  In Vivo Growth Factor Treatment of Degenerated Intervertebral Discs , 2004, Spine.

[20]  T. Albert,et al.  An Organ Culture System for the Study of the Nucleus Pulposus: Description of the System and Evaluation of the Cells , 2003, Spine.

[21]  S. Moon,et al.  Bone Morphogenetic Protein-2 Facilitates Expression of Chondrogenic, not Osteogenic, Phenotype of Human Intervertebral Disc Cells , 2003, Spine.

[22]  Y. Tabata,et al.  Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. , 2003, Biomaterials.

[23]  E. Thonar,et al.  Recombinant osteogenic protein‐1 upregulates extracellular matrix metabolism by rabbit annulus fibrosus and nucleus pulposus cells cultured in alginate beads , 2003, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[24]  K. Ando,et al.  Transplantation of mesenchymal stem cells embedded in Atelocollagen gel to the intervertebral disc: a potential therapeutic model for disc degeneration. , 2003, Biomaterials.

[25]  W. Hutton,et al.  The Effect of Bone Morphogenetic Protein-2 on Rat Intervertebral Disc Cells in Vitro , 2003, Spine.

[26]  T. Nakajima,et al.  Basic Studies on the Clinical Applications of Platelet-Rich Plasma , 2003, Cell transplantation.

[27]  T. Kawase,et al.  Platelet-rich plasma contains high levels of platelet-derived growth factor and transforming growth factor-beta and modulates the proliferation of periodontally related cells in vitro. , 2003, Journal of periodontology.

[28]  M. Aebi,et al.  The Potential and Limitations of a Cell-Seeded Collagen/Hyaluronan Scaffold to Engineer an Intervertebral Disc-Like Matrix , 2003, Spine.

[29]  P. Roughley,et al.  The role of proteoglycans in aging, degeneration and repair of the intervertebral disc. , 2002, Biochemical Society transactions.

[30]  Y. Tabata,et al.  Promoted growth of murine hair follicles through controlled release of basic fibroblast growth factor. , 2002, Tissue engineering.

[31]  E. Thonar,et al.  Osteogenic protein-1 enhances matrix replenishment by intervertebral disc cells previously exposed to interleukin-1. , 2002, Spine.

[32]  G. Hafner,et al.  Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. , 2002, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[33]  J. Mochida,et al.  Nucleus Pulposus Allograft Retards Intervertebral Disc Degeneration , 2001, Clinical orthopaedics and related research.

[34]  S. J. Lee.  Cytokine delivery and tissue engineering. , 2000, Yonsei medical journal.

[35]  J. Mochida,et al.  Reinsertion of stimulated nucleus pulposus cells retards intervertebral disc degeneration: An in vitro and in vivo experimental study , 2000, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[36]  H. Gruber,et al.  Anti-Apoptotic Effects of IGF-1 and PDGF on Human Intervertebral Disc Cells In Vitro , 2000, Spine.

[37]  Y. Ikada,et al.  Bone regeneration by transforming growth factor beta1 released from a biodegradable hydrogel. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[38]  Y Ikada,et al.  Bone regeneration at rabbit skull defects treated with transforming growth factor-beta1 incorporated into hydrogels with different levels of biodegradability. , 2000, Journal of neurosurgery.

[39]  L G Gilbertson,et al.  Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: an in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta 1 encoding gene. , 1999, Spine.

[40]  G. Andersson.  Epidemiological features of chronic low-back pain , 1999, The Lancet.

[41]  Y. Ikada,et al.  Biodegradation of hydrogel carrier incorporating fibroblast growth factor. , 1999, Tissue engineering.

[42]  M Feuerstein,et al.  Health Care and Indemnity Costs Across the Natural History of Disability in Occupational Low Back Pain , 1998, Spine.

[43]  J. Mochida,et al.  Percutaneous Reinsertion of the Nucleus Pulposus: An Experimental Study , 1998, Spine.

[44]  R. Marx,et al.  Platelet-rich plasma: Growth factor enhancement for bone grafts. , 1998, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[45]  Ikada,et al.  Protein release from gelatin matrices. , 1998, Advanced drug delivery reviews.

[46]  H E Gruber,et al.  Human intervertebral disc cells from the annulus: three-dimensional culture in agarose or alginate and responsiveness to TGF-beta1. , 1997, Experimental cell research.

[47]  G. Waddell.  Low Back Pain: A Twentieth Century Health Care Enigma , 1996, Spine.

[48]  K. Yudoh,et al.  Autocrine/paracrine mechanism of insulin‐like growth factor‐1 secretion, and the effect of insulin‐like growth factor‐1 on proteoglycan synthesis in bovine intervertebral discs , 1996, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[49]  Wayne R. Gombotz,et al.  The Enhancement in Wound Healing by Transforming Growth Factor-β1 (TGF-β1) Depends on the Topical Delivery System , 1995 .

[50]  T. Oegema,et al.  Biochemistry of the intervertebral disc. , 1993, Clinics in sports medicine.

[51]  S. Roberts,et al.  The fluid content of the human intervertebral disc. Comparison between fluid content and swelling pressure profiles of discs removed at surgery and those taken postmortem. , 1992, Spine.

[52]  S. Ayad,et al.  1991 Volvo Award in Basic Sciences: Collagen Types Around the Cells of the Intervertebral Disc and Cartilage End Plate: An Immunolocalization Study , 1991, Spine.

[53]  J. P. Thompson,et al.  Stimulation of Mature Canine Intervertebral Disc by Growth Factors , 1991, Spine.

[54]  F. Marchand,et al.  Investigation of the Laminate Structure of Lumbar Disc Anulus Fibrosus , 1990, Spine.

[55]  H. Tsuji,et al.  Water Diffusion Pathway, Swelling Pressure, and Biomechanical Properties of the Intervertebral Disc During Compression Load , 1989, Spine.

[56]  R. Soames,et al.  Human intervertebral disc: Structure and function , 1988, The Anatomical record.

[57]  J. Urban,et al.  Swelling Pressure of the Lumbar Intervertebral Discs: Influence of Age, Spinal Level, Composition, and Degeneration , 1988, Spine.

[58]  Y Ikada,et al.  Neovascularization effect of biodegradable gelatin microspheres incorporating basic fibroblast growth factor. , 1999, Journal of biomaterials science. Polymer edition.

[59]  M. E. Adams,et al.  Degeneration and the chemical composition of the human lumbar intervertebral disc , 1987, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[60]  J. Urban,et al.  Swelling pressure of the inervertebral disc: influence of proteoglycan and collagen contents. , 1985, Biorheology.

[61]  J A Buckwalter,et al.  Ultrastructure of the human intervertebral disc. I. Changes in notochordal cells with age. , 1982, Tissue & cell.

[62]  H. Muir,et al.  Experimental intervertebral disc degeneration: morphologic and proteoglycan changes over time. , 1981, Arthritis and rheumatism.